本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Seres Therapeutics, Inc.

13.82
-0.7100-4.89%
成交量:8.92万
成交额:124.06万
市值:1.21亿
市盈率:1.54
高:15.07
开:15.00
低:13.51
收:14.53
数据加载中...

公司资料

公司名字:
Seres Therapeutics, Inc.
交易所:
NASDAQ
成立时间:
2010
员工人数:
103
公司地址:
101 Cambridgepark Drive,Cambridge,Massachusetts,United States
邮编:
02140
电话:
传真:
- -
简介:
Seres Therapeutics, Inc.于2010年10月根据特拉华州法律注册成立。该公司是一家商业阶段的微生物组疗法公司,专注于一类新型生物药物的开发和商业化,这些药物旨在通过调节微生物组来治疗疾病,通过将被破坏的微生物组的功能修复到非疾病状态来恢复健康。该公司还在设计微生物组疗法,这些疗法经过优化,可以去定植病原体并调节宿主功能,以减少和预防感染并诱导免疫耐受。

董事

名称
职位
Stephen Berenson
Chairman of the Board
Claire M. Fraser
Independent Director
Dennis A. Ausiello
Independent Director
Kurt C. Graves
Independent Director
Paul R. Biondi
Independent Director
Richard N. Kender
Independent Director
Willard H. Dere
Independent Director
Eric D. Shaff
Director
Hans Juergen Woerle
Director

股东

名称
职位
Marella Thorell
Executive Vice President and Chief Financial Officer,Co-Chief Executive Officer and Co-President
Thomas J. DesRosier
Executive Vice President and Chief Legal Officer,Co-Chief Executive Officer and Co-President
Matthew Henn
Executive Vice President and Chief Scientific Officer
Teresa L. Young
Executive Vice President, Chief Commercial Officer and Chief Strategy Officer